Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2026-04-06 @ 6:54 AM
Study NCT ID:
NCT07208058
Status:
RECRUITING
Last Update Posted:
2025-12-02
First Post:
2025-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])
Sponsor:
TJ Biopharma Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
THZ0103-MAS301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None